Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-08-07 17:32:28 ET · period of report 2026-08-06 · accession 0000097745-26-000146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-07 17:32 | 2026-08-06 | TMO | Britt Lisa P. | SVP, Chief HR Off | M - OptEx | $309.63 | +5,850 | 20.6K | +40% | +$1.81M |
| D | 2026-08-07 17:32 | 2026-08-06 | TMO | Britt Lisa P. | SVP, Chief HR Off | S - Sale+OE | $580.00 | -5,850 | 14.8K | -28% | -$3.39M |
| D | 2026-08-07 17:32 | 2026-08-06 | TMO | Britt Lisa P. | SVP, Chief HR Off | M - OptEx | $0.00 | -5,850 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-06 | M | A | 5,850 | $309.63 | 20,634.15 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-06 | S | D | 5,850 | $580.00 | 14,784.15 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-08-06 | M | D | 5,850 | $0.00 | 0 | D | $309.63 · — to 2027-02-25 | 5,850 Common Stock | (F1) The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024. |